First Report

U.S. Patient and Clinician Experiences With the inFlow™ Urinary Prosthesis for Permanent Urinary Retention in Women

Leanne Schimke, MSN, FNP-C, CRNP, CUNP; Kevin M. Connolly


Urol Nurs. 2020;40(2):61-73. 

In This Article


This post-market survey examined patient and caregiver experiences with inFlow, an FDA-approved treatment for PUR among a sample of users with a minimum of 10 months' experience with the device. This is the first report of patient (and caregiver) experiences with inFlow in the United States. In comparison to prior methods of bladder drainage, data indicate the use of inFlow results in a higher degree of satisfaction. Users particularly liked the convenience and hygienic aspects associated with the device, in addition to the ability to use the toilet. Consistent with key findings in the FDA's review, fewer UTIs were reported, and quality of life improved among inFlow users.

There are limitations to this study. Respondents self-selected to complete a self-report survey of items that were not validated. Due to the small sample size, robust statistical analyses could not be conducted. While study findings of a reduced incidence of UTIs and improvements in quality of life-related to inFlow use are consistent with published clinical studies, results cannot be generalized beyond the study sample.